CCL2 was a highly expressed cytokine in HNSCC cells under the serum-deficient condition (Fig. 1A, B), indicating that tumor cells were an important cellular source of CCL2 in the tumor microenvironment. The gene discussed is CCL2; the disease is neoplasm.